The GHRP Class: How GH Secretagogues Work

Growth hormone releasing peptides (GHRPs) stimulate GH release by agonizing the ghrelin receptor (GHS-R1a) in the pituitary and hypothalamus. Ghrelin, the natural ligand, triggers GH pulses as part of the hunger signaling pathway. Synthetic GHRPs — including GHRP-2, GHRP-6, hexarelin, and ipamorelin — mimic this signal to various degrees of potency and selectivity. The key variable across GHRPs is whether they co-stimulate cortisol and prolactin, which is undesirable in research models focused on isolated GH effects.

Ipamorelin's Selectivity Advantage

Ipamorelin is a 5-amino acid GHRP with high GHS-R1a selectivity. Unlike GHRP-2 and GHRP-6, which significantly elevate cortisol and prolactin in addition to GH, ipamorelin produces GH pulses with minimal co-stimulation of these hormones — even at doses that maximize GH output. This makes it the preferred GHRP in research models where cortisol or prolactin elevation would confound results, and it reduces the side effect profile in subjects compared to less selective alternatives.

GH Pulse Kinetics

Ipamorelin produces a rapid, physiological GH pulse. In animal and human studies, peak GH elevation occurs approximately 15–30 minutes post-injection with return to baseline by 3 hours. This pulse mimics the natural pulsatile pattern of GH secretion, which matters in long-term research — sustained supraphysiological GH would cause receptor downregulation. Ipamorelin's short action preserves sensitivity of the GH axis over time.

The Ipamorelin + CJC-1295 Stack Rationale

Ipamorelin is a GHRP — it amplifies the GH pulse by acting on the ghrelin receptor. CJC-1295 is a GHRH analog — it provides the upstream GHRH signal that initiates GH release from somatotrophs. These two peptides act on different steps of the same GH release pathway. Combined, they produce significantly greater GH output than either alone. This combination is the most common growth hormone secretagogue stack in research settings.

COA Standards

Ipamorelin is a 5-amino acid peptide with MW ~711.9 Da. HPLC purity should be ≥99%. MS identity confirmation is recommended. Because ipamorelin is structurally similar to other short GHRPs, identity confirmation ensures the correct sequence is present.